Zoryl MV 2 Tablet SR: A Combination Treatment for Type 2 Diabetes

Zoryl MV 2 Tablet SR combines three powerful medications to help manage type 2 diabetes effectively: Glimepiride (2mg), Metformin (500mg), and Voglibose (0.2mg). This unique combination offers a comprehensive approach to blood glucose control.

Glimepiride: Primarily acts on the pancreas, increasing insulin release to lower blood sugar levels.
Metformin: Improves insulin sensitivity, reducing glucose production in the liver, and lowering the body's response to food intake.
Voglibose: Acts directly on the intestines by inhibiting glucosyltransferase, a protein that increases glucose absorption from food.

These medications work synergistically to provide comprehensive blood sugar control. This combination therapy is suitable for patients with type 2 diabetes who need assistance managing their condition and achieving optimal glycemic control. Always consult your physician before starting or changing any medication regimen.

Note: Consult with a healthcare professional before taking any new medication, as individual needs may vary.